Efficacy of TR 987, Beta-1,3-1,6-D-glucan, in the Treatment of Chronic Venous Insufficiency Ulcers

NCT03154619 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

80

Enrollment

NETWORK

Sponsor class

Conditions

Venous Leg Ulcer

Interventions

DRUG: 0.1% TR 987
DRUG: Placebo gel

Sponsor

SerenaGroup, Inc.

Collaborators

[object Object]